References
1a
Fedson DS.
Anthony J.
Scott G.
Vaccine
1999,
17:
S11
1b
Poland GA.
Vaccine
1999,
17:
1674
2a
Jones C.
Carbohydr. Eur.
1998,
21:
10
2b
Musher DM.
Clin. Infect. Dis.
1991,
14:
801
3 See for example: Austrian R.
Vaccine
2001,
19:
S71
4 See for example: Arndt B.
Porro M. In
Immunobiology of Proteins and Peptides VI
Atassi MZ.
Plenum Press;
New York:
1991.
p.129
5
Redlich H.
Sudau W.
Szadenings AK.
Vollerthun R.
Carbohydr. Res.
1992,
226:
57
6a
Gaunt MJ.
Yu J.
Spencer JB.
J. Org. Chem.
1998,
63:
4172
6b
Wright JA.
Yu J.
Spencer JB.
Tetrahedron Lett.
2001,
42:
4033
6c
Xia J.
Abbas SA.
Locke RD.
Piskorz CF.
Alderfer JL.
Matta KL.
Tetrahedron Lett.
2000,
41:
169
6d
Liao W.
Locke RD.
Matta KL.
Chem. Commun.
2000,
369
6e
Xia J.
Alderfer JL.
Piskorz CF.
Matta KL.
Chem.-Eur. J.
2001,
7:
356
7
Bianco A.
Brufani M.
Manna F.
Melchioni C.
Carbohydr. Res.
2001,
332:
23
8
Fernández S.
Díaz M.
Ferrero M.
Gotor V.
Tetrahedron Lett.
1997,
38:
5225
9
Wang Z.-X.
Miller SM.
Anderson OP.
Shi Y.
J. Org. Chem.
2001,
66:
521
10
Lautens M.
Stammers TA.
Synthesis
2002,
1993
11
Marshall JA.
Bourbeau MP.
Org. Lett.
2002,
4:
3931
12
Bessodes M.
Shamsazar J.
Antonakis K.
Synthesis
1988,
560
13 All new compounds have been characterized by proton and carbon NMR, exact mass, and/or elemental analysis. Spectroscopic data for selected compounds:
5a-Carba-2,3-
O
-cyclohexylidene-1-
O
-naphtylmetyl-α-
l-rhamno-pyranoside (
11a): 1H NMR (300 MHz, CDCl3): δ = 1.05 (d, 3 H, J
Me,5 = 6.0 Hz, Me), 1.30-1.80 (m, 12 H,
H-5a and 5 CH2), 1.80-2.00 (m, 1 H, H-5), 3.30 (dd, 1 H, J
3,4 = 7.7 Hz, J
4,5 = 9.9 Hz, H-4), 3.90 (br m, 1 H, H-1), 4.05 (dd, 1 H, J
2,3 = 5.8 Hz, J
3,4 = 7.7 Hz, H-3), 4.29 (br m, 1 H, H-2), 4.72 and 4.78 (ABq, 2 H, CH2-Nap), 7.20-7.90 (m, 7 H, Ar H). 13C NMR (75.4 MHz, CDCl3): δ = 18.21 (q, CH3), 23.81 (t), 24.17 (t), 25.13 (t), 30.06 (d, C-5), 32.60 (t), 35.41 (t), 38.10 (t), 71.32 (t), 74.15 (d), 76.71 (d), 78.12 (d), 80.22 (d), 109.74 (s), 125.99 (d), 126.24 (d, 2 C), 127.79 (d), 127.96 (d), 128.31 (d, 2 C), 133.09 (s), 133.37 (s), 135.77 (s). [α]D
25 +15.7 (c = 1, CHCl3). Mp 99.0-101.0 °C.
5a-Carba-1-naphtylmetyl-3,4-dibenzyl-α-
l-rhamno-pyranoside (14a,b): 1H NMR (300 MHz, CDCl3): 1.10 (d, 3 H, J
6,5 = 6.6 Hz, H-6), 1.62 (dt, 1 H, J
5aA,5aB = J
5aA,5 = 14.5 Hz, J
5aA,1 = 2.5 Hz, H-5aA), 1.86 (dt, 1 H, J
5aA,5aB = 14.5 Hz, J
5aB,5 = J
5aB,1 = 2.7 Hz, H-5aB), 1.97-2.17 (m, 1 H, H-5), 2.58 (br s, 1 H, -OH), 3.39 (t, 1 H, J
3,4 = J
4,5 = 9.1 Hz, H-4), 3.80 (br m, 1 H, H-1), 3.86 (dd, 1 H, J
2,3 = 3.3 Hz, J
3,4 = 9.1 Hz, H-3), 4.19 (br t, 1 H, H-2), 4.55-5.00 (m, 6 H, 3 ABq, CH2-Nap and CH2-Bn), 7.10-8.00 (m, 17 H, Ar H). 13C NMR (75.4 MHz, CDCl3): δ = 18.34 (q, C-6), 31.78 (d,
C-5), 32.05 (t, C-5a), 69.74 (d), 71.20 (t), 72.69 (t), 75.43 (t), 76.16 (d), 82.33 (d), 83.32 (d), 125.71 (d), 125.96 (d), 126.15 (d), 126.25 (d), 127.64 (d), 127.83 (d), 127.92 (d), 127.99 (d), 128.02 (d, 2 C), 128.13 (d, 2 C), 128.24 (d), 128.47 (d, 2 C), 128.60 (d, 2 C), 133.08 (s), 133.40 (s), 136.20 (s), 138.51 (s), 139.14 (s). [α]D
25 -18.3 (c = 1, CHCl3).
14
Takahashi T.
Kotsubo H.
Iyobe A.
Namiki T.
Koizumi T.
J. Chem. Soc., Perkin Trans. 1
1990,
3065
15 The stereochemistry of compounds 11a and 11b was inferred from the coupling constants of the signal of H-C(4) in 1H NMR spectrum. In fact, H-C(4) appeared as a doublet of doublets for both compounds, but in 11a the 3
J were 7.7 Hz and 9.9 Hz, while in compound 11b the constants were 10.8 Hz and 3.2 Hz. Furthermore, H-C(4) in compound 13 appeared as a triplet with a 3
J of 9.9 Hz, clearly indicating the axial orientation of H-C(4) in a chair conformation of 13.
16
Shing TKM.
Cui Y.
Tang Y.
Tetrahedron
1992,
48:
2349
17
David S.
Hanessian S.
Tetrahedron
1985,
41:
643